Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

2. Calcium

Calcium Top results for calcium - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for calcium The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you

2018 Trip Latest and Greatest

3. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Full Text available with Trip Pro

Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Pre-eclampsia is considerably more prevalent in low- than high-income countries. One possible explanation for this discrepancy is dietary differences, particularly calcium deficiency. Calcium supplementation in the second half of pregnancy reduces the serious consequences of pre-eclampsia and is recommended by the World Health Organization (WHO (...) ) for women with low dietary calcium intake, but has limited effect on the overall risk of pre-eclampsia. It is important to establish whether calcium supplementation before and in early pregnancy has added benefit. Such evidence would be justification for population-level fortification of staple foods with calcium.To determine the effect of calcium supplementation or food fortification with calcium, commenced before or early in pregnancy and continued at least until mid-pregnancy, on pre-eclampsia

2017 Cochrane

4. Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. Full Text available with Trip Pro

Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. Preeclampsia is an important cause of maternal and perinatal morbidity and mortality. Previous studies have tested calcium supplementation and aspirin separately to reduce the incidence of preeclampsia but not the effects of combined supplementation. The objective of this study was to investigate the effectiveness of aspirin combined with calcium supplementation to prevent preeclampsia in women (...) with chronic hypertension. A double-blind, placebo-controlled randomized clinical trial was carried out at the antenatal clinic of a large university hospital in São Paulo, SP, Brazil. A total of 49 women with chronic hypertension and abnormal uterine artery Doppler at 20-27 weeks gestation were randomly assigned to receive placebo (N = 26) or 100 mg aspirin plus 2 g calcium (N = 23) daily until delivery. The main outcome of this pilot study was development of superimposed preeclampsia. Secondary outcomes

2014 Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] Controlled trial quality: predicted high

5. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. (Abstract)

Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. The hypertensive disorders of pregnancy include pre-eclampsia, gestational hypertension, chronic hypertension, and undefined hypertension. Pre-eclampsia is considerably more prevalent in low-income than in high-income countries. One possible explanation for this discrepancy is dietary differences, particularly calcium deficiency. Calcium supplementation in the second half (...) of pregnancy reduces the serious consequences of pre-eclampsia, but has limited effect on the overall risk of pre-eclampsia. It is important to establish whether calcium supplementation before, and in early pregnancy (before 20 weeks' gestation) has added benefit. Such evidence could count towards justification of population-level interventions to improve dietary calcium intake, including fortification of staple foods with calcium, especially in contexts where dietary calcium intake is known

2019 Cochrane

6. Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. (Abstract)

Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. Post-surgical hypoparathyroidism is a common complication after thyroid surgery. The incidence is likely to increase given the rising trend in the annual number of thyroid operations being performed. Measures to prevent post-thyroidectomy hypoparathyroidism including different surgical techniques and prophylactic calcium and vitamin D supplements have been extensively studied (...) . The management of post-thyroidectomy hypoparathyroidism however has not been extensively evaluated. Routine use of calcium and vitamin D supplements in the postoperative period may reduce the risk of symptoms, temporary hypocalcaemia and hospital stay. However, this may lead to overtreatment and has no effect on long-term hypoparathyroidism. Current recommendations on the management of post-thyroidectomy hypoparathyroidism is based on low-quality evidence. Existing guidelines do not often distinguish between

2019 Cochrane

7. Does vitamin D without calcium reduce fracture risk?

Does vitamin D without calcium reduce fracture risk? Does vitamin D without calcium reduce fracture risk? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Does vitamin D without calcium reduce fracture risk? View/ Open Date 2016-12 Format Metadata Abstract Q: Does vitamin D without calcium reduce fracture risk? Evidence (...) -based answer: No. Supplemental vitamin D without calcium -- in doses averaging as much as 800 IU per day -- doesn't reduce the risk of hip, vertebral, or nonvertebral fractures in postmenopausal women and older men (strength of recommendation [SOR]: A, large, high-quality meta-analysis of randomized or quasirandomized placebo-controlled trials). The vitamin D analogs alfacalcidol and calcitriol also don't reduce hip or nonvertebral fractures (SOR: A, multiple randomized, controlled trials [RCTs

2017 Clinical Inquiries

8. Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults

Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation HAYES, Inc. Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults. Lansdale: HAYES, Inc. Directory Publication. 2017 Authors' conclusions Coronary artery calcium (CAC) scoring uses computed tomography scanning to detect and assess the extent of atherosclerosis and quantifies the findings using a scoring system to assess and stratify risk of coronary artery disease in asymptomatic

2017 Health Technology Assessment (HTA) Database.

9. The methodological quality of guideline recommendations on vitamin D and calcium intakes: a systematic review of food-based dietary guidelines and osteoporosis prevention guidelines

The methodological quality of guideline recommendations on vitamin D and calcium intakes: a systematic review of food-based dietary guidelines and osteoporosis prevention guidelines Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

10. Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation

Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation TITLE: Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation: A Review of the Clinical Effectiveness DATE: 26 June 2014 CONTEXT AND POLICY ISSUES Constipation has many definitions and is often described differently depending on the population queried. Many physicians define constipation as a reduction in the frequency of bowel movements (...) or bulking agents (i.e. psyllium seed husk), osmotic laxatives (i.e. lactulose, sorbitol, polyethylene glycol [PEG]), stimulant laxatives (i.e. sennosides, bisacodyl, sodium picosulfate), and stool softeners (i.e. docusate sodium or calcium). 1,2 In North America, docusate and a stimulant laxative such as sennosides are commonly used in bowel treatment protocols associated with institutionalized elderly 4 and oncology treatments. 5 A paucity of evidence is available to support the use of the stool

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

11. Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium

Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium Torgerson D J, Kanis J A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Ergocalciferol and calciferol (Vitamins D) and calcium supplementation. Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Study population Elderly women with and without a low body mass index (BMI) (high risk group). Setting Community and nursing homes. Dates to which data relate The effectiveness data relate

1995 NHS Economic Evaluation Database.

12. NovaMin (Calcium Sodium Phosphosilicate) Dentifrices Reduce Dentinal Hypersensitivity More Than Potassium Nitrate Dentifrices

NovaMin (Calcium Sodium Phosphosilicate) Dentifrices Reduce Dentinal Hypersensitivity More Than Potassium Nitrate Dentifrices UTCAT3059, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title NovaMin (Calcium Sodium Phosphosilicate) Dentifrices Reduce Dentinal Hypersensitivity More Than Potassium Nitrate Dentifrices Clinical Question In healthy adult patients, do NovaMin dentifrices reduce symptoms of dentinal (...) -treatment data). A similar but longer trial might simulate real-world use of these products better. Applicability Dentinal hypersensitivity is a common condition, and many patients ask their dentist or hygienist for treatment recommendations. NovaMin and potassium nitrate are dentifrices that are applied in the same manner and provide a noninvasive treatment option for patients with dentinal hypersensitivity. The cost of NovaMin (calcium sodium phosphosilcate) dentifrices is slightly greater than

2016 UTHSCSA Dental School CAT Library

13. Calcium and Vitamin D Supplementation for Adults: Safety and Guidelines

Calcium and Vitamin D Supplementation for Adults: Safety and Guidelines Calcium and Vitamin D Supplementation for Adults: Safety and Guidelines | CADTH.ca Find the information you need Calcium and Vitamin D Supplementation for Adults: Safety and Guidelines Calcium and Vitamin D Supplementation for Adults: Safety and Guidelines Last updated: June 7, 2018 Project Number: RB1229-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What (...) is the clinical evidence for the safety of calcium and vitamin D supplementation in adults? What are the evidence-based guidelines regarding the use of calcium and vitamin D supplements in the general adult population? Key Message Thirteen systematic reviews (seven with meta-analyses), 30 randomized controlled trials, and seven evidence based guidelines were identified regarding calcium and vitamin D supplementation in adults. Files Rapid Response Summary of Abstracts Published : June 7, 2018 Related Content

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

14. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement. (Abstract)

Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement. Because of the aging population, osteoporotic fractures are an increasingly important cause of morbidity and mortality in the United States. Approximately 2 million osteoporotic fractures occurred in the United States in 2005, and annual incidence is projected to increase to more than 3 million fractures by 2025. Within (...) 1 year of experiencing a hip fracture, many patients are unable to walk independently, more than half require assistance with activities of daily living, and 20% to 30% of patients will die.To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on vitamin D supplementation, with or without calcium, to prevent fractures.The USPSTF reviewed the evidence on vitamin D, calcium, and combined supplementation for the primary prevention of fractures in community-dwelling adults

2018 JAMA

15. Vitamin D and Calcium Supplementation in Elderly Patients Suffering Fragility Fractures; The Road not Taken Full Text available with Trip Pro

Vitamin D and Calcium Supplementation in Elderly Patients Suffering Fragility Fractures; The Road not Taken Calcium and Vitamin D supplementation in elderly patients may decrease the risk of hip fracture by up to one-third. Many patients suffering fragility fractures do not go on to receive this treatment despite clear recommendations from the National Institute for Health and Clinical Excellence (NICE). The aim of this study was to audit the proportion of patients admitted with a hip fracture (...) who had suffered a previous fragility fracture and were taking calcium and vitamin D supplements, with the standard being that all of these patients should have been taking bone protection. We also aimed to assess the Vitamin D levels of patients admitted with a hip fracture to our unit.Patients were prospectively added to a database over a 12-month period. Serum vitamin D levels (25-OH D3) were measured on admission and case-notes were reviewed for pre-injury social function and mobility.147

2017 The open orthopaedics journal

16. Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness

Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness CADTH Record Status This is a bibliographic record of a published (...) health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions There remains a paucity of good quality evidence to support the use of docusate

2014 Health Technology Assessment (HTA) Database.

17. Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK

Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK | Great Ormond Street Hospital Google Tag Manager Navigation Search Search You are here Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D (...) for children and young people with neuromuscular disorders in the UK Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK ). Children with reduced exposure to sunlight (such as those who have poor mobility, those with clothing that limits exposure ( ). Children (particularly those with Duchenne Muscular Dystrophy) who are at increased risk of fracture as a result of long term steroid use ( ). Children

2014 Publication 1593

18. Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality. (Abstract)

Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality. Prospective, controlled clinical trials in postmenopausal osteoporosis typically compare effects of an active drug with placebo in addition to vitamin D and calcium supplementation in both treatment arms. While clinical benefits are documented, the effect of this supplementation in the placebo arm and in clinical practice on bone material composition (...) properties is unknown. The purpose of the present study was to evaluate these bone quality indices (specifically mineral/matrix, nanoporosity, glycosaminoglycan content, mineral maturity/crystallinity, and pyridinoline content) in patients that either received long-term vitamin D (400-1200IU) and calcium (1.0-1.5g) supplementation, or did not. We have analyzed by Raman microspectroscopy the bone forming trabecular surfaces of iliac crest in pre-treatment samples of a teriparatide study and the endpoint

2016 Bone

19. Is Adenosine or an Intravenous Calcium Channel Blocker More Effective for Treating Supraventricular Tachycardia? (SRS therapy)

Is Adenosine or an Intravenous Calcium Channel Blocker More Effective for Treating Supraventricular Tachycardia? (SRS therapy) TAKE-HOME MESSAGE Among patients presenting with supraventricular tachycardia, rates of reversion to sinus rhythm and hypotension were similar between patients who were given adenosine or calcium channel blockers. Is Adenosine or an Intravenous Calcium Channel Blocker More Effective for Treating Supraventricular Tachycardia? EBEM Commentators Michael Gottlieb, MD (...) studies, although one study had both a verapamil and a diltiazem treat- ment arm. There was no difference in the rates of reversion to sinus rhythm between adenosine and calcium channel antagonists (Table). Three trials reported on hypotension, with only one case identi?ed in the calcium channel antagonist group. Four studies, comprising 442 patients, evaluated time to reversion, with a signi?cantly reduced time in the adenosine group (mean¼44 seconds) compared with the calcium channel antago- nist

2018 Annals of Emergency Medicine Systematic Review Snapshots

20. Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi

Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi BestBets: Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Report By: Alexander Stewart - 4th Year Medical Student Search checked by Craig Ferguson - Consultant in Emergency Medicine Institution: Manchester University Date Submitted: 11th July 2012 Date Completed: 17th April 2013 Last Modified (...) : 17th April 2013 Status: Green (complete) Three Part Question In [adult patients with urinary calculi] is [treatment with alpha receptor blockers superior to treatment with calcium channel antagonists] at [increasing the speed and success of spontaneous stone passage]? Clinical Scenario A 51 year old presents to A&E with loin pain and macroscopic haematuria and a diagnosis of renal calculi is made. The patient’s pain is adequately controlled and the decision is discharge with Medical Expulsive

2013 BestBETS